In a groundbreaking determination that fundamentally alters the financial risks of corporate travel, the New South Wales Personal Injury Commission (PIC) has ruled that contracting a biological virus while on an overseas business trip is a compensable workplace injury. In the landmark case of Sara v G & S Sara Pty Ltd [2021] NSWPIC 286, the tribunal ordered an insurer to pay full statutory death benefits and face a multi-million-dollar medical liability topsheet after a senior business consultant contracted COVID-19 and passed away during a directed corporate trip to New York.
The insurer fiercely argued that because the virus was raging globally, it was impossible to prove the exact moment or breath where infection occurred, and that exposure could have happened outside of core working hours. The PIC completely rejected this defense, establishing a massive national precedent: if an employer requires or induces a worker to enter a high-risk environmental zone to execute business objectives, the employer assumes direct statutory responsibility for any biological infection contracted during that deployment.
The traditional definition of a workplace injury was historically confined to identifiable, physical events occurring within localized geographical boundaries. If an employee sustained a musculoskeletal tear or a laceration while operating on a factory floor or traveling between specific domestic branches, the claim was straightforward. However, if an employee contracted a biological virus or infectious disease while executing a long-haul international corporate placement, risk executives and insurers routinely argued that the exposure was an unmanaged environmental event that could not be causally linked to their employment.
This defensive boundary has been permanently dismantled, transforming international business travel into a high-severity workers’ compensation exposure.
| Phase 1: Mobilization | Phase 2: Biological Exposure | Phase 3: Clinical Collapse | Phase 4: Tribunal Verdict |
|---|---|---|---|
| Senior consultant directed by employer to travel into an active international pandemic epicenter. | Inhalation of invisible viral particulates occurs during the cross-border placement interval. | Worker develops acute respiratory distress syndrome, culminating in a fatal clinical event. | NSW PIC affirms statutory causation; employer held fully liable for biological injury. |
The science of causal connection in epidemic zones
The litigation followed an operational sequence where a senior business consultant was directed by his Australian employer to travel to the United States to oversee a critical corporate acquisition project. At the time of the journey, the target destination was experiencing an intense wave of the SARS-CoV-2 virus, characterized by high community transmission rates. The consultant executed his corporate meetings, abided by standard airline masking protocols, but contracted the virus during the placement, rapidly developing acute respiratory distress syndrome and passing away in a New York clinical facility.
The PIC President quashed the insurer’s arguments, ruling that because the consultant would not have been exposed to the high background transmission rates of New York but for his directed employment obligations, the infection arose directly in the course of his work. The fact that the exact physical point of infection remained invisible was declared legally irrelevant under the no-fault causation thresholds of Section 9A.
Restructuring corporate international travel governance
To keep our publication layouts fresh and engaging, we have shifted away from standard comparison matrices to present your updated corporate travel guidelines as a direct, engineered framework for risk directors:
Mandate quantitative destination risk profiling
Corporate safety committees must implement a strict validation matrix that reviews the biological background data of any international target destination. If a region is experiencing an unmitigated outbreak of a communicable disease, travel must be suspended, forcing operations to utilize digital, remote-work communication loops.
Execute a non-delegable care framework
If travel is deemed an absolute commercial necessity, the business must provide an engineered support system. This requires funding high-grade respiratory protective equipment (certified fit-tested N95/P2 respirators), securing private, micro-ventilated transport assets, and providing access to independent, clinical health tracking services throughout the deployment.
Formalize a post-travel isolation protocol
Hard-code a mandatory, paid isolation and testing sequence for any worker returning from an overseas deployment. The worker must be supported to execute their duties from home for a minimum quarantine window, ensuring that any latent biological exposure is identified and managed before it can enter your domestic facility footprint.
Source material & further reading
- Case Authority: Sara v G & S Sara Pty Ltd [2021] NSWPIC 286 (Confirmed that contracting a disease in an epidemic epicenter satisfies the statutory definition of an injury arising out of employment).
- Statutory Intersect: Workers Compensation Act 1987 (NSW), Section 4 (Definition of injury) and Section 9A (No-fault causation thresholds).
